- Home
- BEEM vs ITRM Comparison
BEEM vs ITRM Comparison
Compare BEEM & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEEM
- ITRM
- Stock Information
- Founded
- BEEM 2006
- ITRM 2015
- Country
- BEEM United States
- ITRM Ireland
- Employees
- BEEM N/A
- ITRM N/A
- Industry
- BEEM Semiconductors
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- BEEM Technology
- ITRM Health Care
- Exchange
- BEEM Nasdaq
- ITRM Nasdaq
- Market Cap
- BEEM 35.5M
- ITRM 40.0M
- IPO Year
- BEEM N/A
- ITRM 2018
- Fundamental
- Price
- BEEM $2.52
- ITRM $0.74
- Analyst Decision
- BEEM Strong Buy
- ITRM Strong Buy
- Analyst Count
- BEEM 4
- ITRM 2
- Target Price
- BEEM $5.33
- ITRM $7.00
- AVG Volume (30 Days)
- BEEM 200.0K
- ITRM 1.1M
- Earning Date
- BEEM 08-14-2025
- ITRM 08-05-2025
- Dividend Yield
- BEEM N/A
- ITRM N/A
- EPS Growth
- BEEM N/A
- ITRM N/A
- EPS
- BEEM N/A
- ITRM N/A
- Revenue
- BEEM $33,362,000.00
- ITRM N/A
- Revenue This Year
- BEEM N/A
- ITRM N/A
- Revenue Next Year
- BEEM $38.51
- ITRM $270.19
- P/E Ratio
- BEEM N/A
- ITRM N/A
- Revenue Growth
- BEEM N/A
- ITRM N/A
- 52 Week Low
- BEEM $1.33
- ITRM $0.66
- 52 Week High
- BEEM $5.90
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- BEEM 56.64
- ITRM 39.91
- Support Level
- BEEM $2.31
- ITRM $0.71
- Resistance Level
- BEEM $2.77
- ITRM $0.91
- Average True Range (ATR)
- BEEM 0.21
- ITRM 0.06
- MACD
- BEEM -0.01
- ITRM 0.01
- Stochastic Oscillator
- BEEM 62.69
- ITRM 34.80
About BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.